The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction

N-formyl peptide receptors (FPRs) were first identified upon phagocytic leukocytes, but more than four decades of research has unearthed a plethora of non-myeloid roles for this receptor family. FPRs are expressed within neuronal tissues and markedly in the central nervous system, where FPR interact...

Full description

Bibliographic Details
Main Authors: Peter J.G. Cussell, Margarita Gomez Escalada, Nathaniel G.N. Milton, Andrew W.J. Paterson
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=7;spage=1191;epage=1198;aulast=Cussell
_version_ 1818412023110696960
author Peter J.G. Cussell
Margarita Gomez Escalada
Nathaniel G.N. Milton
Andrew W.J. Paterson
author_facet Peter J.G. Cussell
Margarita Gomez Escalada
Nathaniel G.N. Milton
Andrew W.J. Paterson
author_sort Peter J.G. Cussell
collection DOAJ
description N-formyl peptide receptors (FPRs) were first identified upon phagocytic leukocytes, but more than four decades of research has unearthed a plethora of non-myeloid roles for this receptor family. FPRs are expressed within neuronal tissues and markedly in the central nervous system, where FPR interactions with endogenous ligands have been implicated in the pathophysiology of several neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease, as well as neurological cancers such as neuroblastoma. Whilst the homeostatic function of FPRs in the nervous system is currently undefined, a variety of novel physiological roles for this receptor family in the neuronal context have been posited in both human and animal settings. Rapid developments in recent years have implicated FPRs in the process of neurogenesis and neuronal differentiation which, upon greater characterisation, could represent a novel pharmacological target for neuronal regeneration therapies that may be used in the treatment of brain/spinal cord injury, stroke and neurodegeneration. This review aims to summarize the recent progress made to determine the physiological role of FPRs in a neuronal setting, and to put forward a case for FPRs as a novel pharmacological target for conditions of the nervous system, and for their potential to open the door to novel neuronal regeneration therapies.
first_indexed 2024-12-14T10:40:43Z
format Article
id doaj.art-18c92270eef14567b7384fb6ef802e21
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-14T10:40:43Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-18c92270eef14567b7384fb6ef802e212022-12-21T23:05:41ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742020-01-011571191119810.4103/1673-5374.272566The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunctionPeter J.G. CussellMargarita Gomez EscaladaNathaniel G.N. MiltonAndrew W.J. PatersonN-formyl peptide receptors (FPRs) were first identified upon phagocytic leukocytes, but more than four decades of research has unearthed a plethora of non-myeloid roles for this receptor family. FPRs are expressed within neuronal tissues and markedly in the central nervous system, where FPR interactions with endogenous ligands have been implicated in the pathophysiology of several neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease, as well as neurological cancers such as neuroblastoma. Whilst the homeostatic function of FPRs in the nervous system is currently undefined, a variety of novel physiological roles for this receptor family in the neuronal context have been posited in both human and animal settings. Rapid developments in recent years have implicated FPRs in the process of neurogenesis and neuronal differentiation which, upon greater characterisation, could represent a novel pharmacological target for neuronal regeneration therapies that may be used in the treatment of brain/spinal cord injury, stroke and neurodegeneration. This review aims to summarize the recent progress made to determine the physiological role of FPRs in a neuronal setting, and to put forward a case for FPRs as a novel pharmacological target for conditions of the nervous system, and for their potential to open the door to novel neuronal regeneration therapies.http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=7;spage=1191;epage=1198;aulast=Cussellalzheimer’s disease; formyl peptide receptor; neural regeneration; neuroblastoma; neurodegeneration; neuroinflammation; neuronal differentiation; stroke
spellingShingle Peter J.G. Cussell
Margarita Gomez Escalada
Nathaniel G.N. Milton
Andrew W.J. Paterson
The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction
Neural Regeneration Research
alzheimer’s disease; formyl peptide receptor; neural regeneration; neuroblastoma; neurodegeneration; neuroinflammation; neuronal differentiation; stroke
title The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction
title_full The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction
title_fullStr The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction
title_full_unstemmed The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction
title_short The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction
title_sort n formyl peptide receptors contemporary roles in neuronal function and dysfunction
topic alzheimer’s disease; formyl peptide receptor; neural regeneration; neuroblastoma; neurodegeneration; neuroinflammation; neuronal differentiation; stroke
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=7;spage=1191;epage=1198;aulast=Cussell
work_keys_str_mv AT peterjgcussell thenformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT margaritagomezescalada thenformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT nathanielgnmilton thenformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT andrewwjpaterson thenformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT peterjgcussell nformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT margaritagomezescalada nformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT nathanielgnmilton nformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction
AT andrewwjpaterson nformylpeptidereceptorscontemporaryrolesinneuronalfunctionanddysfunction